Global Regenerative Medicine Market: Analysis By Type (Cell Therapy, Tissue Engineered, Gene Therapy), By Application, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)

Global Regenerative Medicine Market: Analysis By Type (Cell Therapy, Tissue Engineered, Gene Therapy), By Application, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)

Executive Summary

As stated by the research report published by Azoth Analytics in August 2019, the Global Regenerative Medicine Market was valued at USD 22,814.45 million the year 2018. Driven by a number of differentiated fundamental factors including rise in the prevalence of chronic diseases and increase in medical research investments, the global market for regenerative medicine has been advancing at an augmented pace. The growth has been primarily driven by the search to find permanent cure of large number of incurable diseases such as various autoimmune and metabolic ailments,

cancer, neurodegenerative disorders among others.

Over the recent years, regenerative medicine market has been witnessing considerable growth on the back of rising incidence of chronic diseases, rapidly growing medical research facilities, increasing investment by pharmaceutical manufacturers, and growing government initiatives. In addition, expanding product pipeline of companies and growing number of partnerships and collaborative agreements in this industry is anticipated to fuel the market growth in forecast period. However, high cost associated with the manufacturers and use of regenerative therapy has been hindering market growth.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of regenerative medicine market. The report analyses the Global Regenerative Medicine Market By Type (Cell Therapy, Gene Therapy, Tissue Engineered) and By Application (Orthopaedic and Dental, Cardiology, Wound Healing, Metabolism and Inflammation, Immunology & Oncology, Others). The global regenerative medicine market has been analyzed By Region (North America, Europe, Asia Pacific, and ROW) and By Country (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Brazil) for the historical period of 2014-2018 and the forecast period of 2019-2024.

Scope of the Report

Global Regenerative Medicine Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others
Regional Regenerative Medicine Market – North America, Europe, Asia Pacific, ROW (Actual Period: 2014-2018, Forecast Period: 2019-2024)
  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others
Country Regenerative Medicine Market – U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and Brazil (Actual Period: 2014-2018, Forecast Period: 2019-2024)
  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others
Other Report Highlights
  • Competitive Landscape:
  • Company Share Analysis
  • Collaborations, Partnerships and Alliances between Key Industry Players
  • Approved Product Analysis
  • Product Pipeline Analysis
  • Market Dynamics – Drivers and Restraints.
  • Market Trends
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis – Vericel, Gilead Sciences, Novartis, Spark Therapeutics, Orchard Therapeutics, MolMed, Celgene, Sanofi, Amgen, Shanghai Sunway Biotech.


1.Research Methodology
2.Executive Summary
3.Strategic Recommendations
4.Regenerative Medicine Market: Product Outlook
5.Global Regenerative Medicine Market: Growth and Forecast
Table 1: Global Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
Table 2: Global Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 3: Global Number of regenerative medicine Companies, By Region, 2018
Table 4: Biotechnology Research and Development Services Cost Index, In 2018
Table 5: Clinical trials of regenerative medicine, By Type, In number, In 2018
Table 6: Clinical trials of regenerative medicine, By Application, In number, In 2018
Table 7: Financing for Regenerative Medicines, By Type, In USD million, In 2018
Table 8: Financing for Regenerative Medicines, By Organizations, In USD million, In 2018
Table 9: Causes of premature (under age 70) NCD mortality, 2017 (%)
Table 10: Number of New Cases of Cancer, In 2018, By Type, (% of Total)
Table 11: Number of New Cases of Cancer, In 2018, By Region, (% of Total)
Table 12: Prevalence of Diagnosed Autoimmune Diseases, In 2018, By Selected Countries, (% of Total)
Table 13: Number of people with diabetes, Worldwide, (In million), 2017 & 2045E
Table 14: Projected increase in cases of diabetes in 2045, By region (In Percentage)
Table 15: Prevalence of musculoskeletal condition worldwide, 2013-2020E, In billion
Table 16: Prevalence of cardiovascular diseases worldwide, 2013-2018, In million
Table 17: Prevalence of chronic respiratory diseases worldwide, 2013-2020E, In million
Table 18: Prevalence of skin diseases worldwide, 2013-2020E, In million
Table 19: GDP Per Capita PPP, By Region, In 2018 (in Thousand USD)
Table 20: Projected global population aged 60 years & above (In Millions)
6.Global Regenerative Medicine Market: Segment Analysis
6.1 Global Regenerative Medicine Market Size, By Type: Breakdown (%)
Table 21: Global Regenerative Medicine Market Size, By Type, 2018 (%)
Table 22: Global Regenerative Medicine Market Size, By Type, 2024F (%)
6.1.1 Global Regenerative Medicine Market Size, By Type, 2018 (%)
Table 23: Global Regenerative Medicine Market Size, By Type, 2018 (In %)
6.1.2 Global Regenerative Medicine Market Size, By Type, 2024 (%)
Table 24: Global Regenerative Medicine Market Size, By Type, 2024 (In %)
6.2 Global Cell Therapy Regenerative Medicine Market, By Value (2014-2024)
Table 25: Global Cell Therapy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 26: Global Cell Therapy Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
6.3 Global Gene Therapy Regenerative Medicine Market, By Value (2014-2024)
Table 27: Global Gene Therapy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 28: Global Gene Therapy Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
6.4 Global Tissue Engineered Regenerative Medicine Market, By Value (2014-2024)
Table 29: Global Tissue Engineered Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 30: Global Tissue Engineered Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
6.5 Market attractiveness of Global Regenerative Medicine Market- By Type
Table 31: Market Opportunity Chart of global regenerative medicine Market - By Type, By Value (Year - 2024)
6.6 Global Regenerative Medicine Market Size, By Application: Breakdown (%)
Table 32: Global Regenerative Medicine Market Size, By Application, 2018 (%)
Table 33: Global Regenerative Medicine Market Size, By Application, 2024F (%)
6.6.1 Global Regenerative Medicine Market Size, By Application, 2018 (%)
Table 34: Global Regenerative Medicine Market Size, By Application, 2018 (In %)
6.6.2 Global Regenerative Medicine Market Size, By Application, 2024 (%)
Table 35: Global Regenerative Medicine Market Size, By Application, 2024 (In %)
6.7 Global Orthopaedic & Dental Regenerative Medicine Market, By Value (2014-2024)
Table 36: Global Orthopaedic & Dental Market, By Value, 2014-2018 (USD Million)
Table 37: Global Orthopaedic & Dental Market, By Value, Forecast, 2019-2024 (USD Million)
6.8 Global Cardiology Regenerative Medicine Market, By Value (2014-2024)
Table 38: Global Cardiology Market, By Value, 2014-2018 (USD Million)
Table 39: Global Cardiology Market, By Value, Forecast, 2019-2024 (USD Million)
6.9 Global Wound healing Regenerative Medicine Market, By Value (2014-2024)
Table 40: Global Wound Healing Market, By Value, Forecast, 2019-2024 (USD Million)
Table 41: Global Wound Healing Market, By Value, Forecast, 2019-2024 (USD Million)
6.10 Global Metabolism & Inflammation Regenerative Medicine Market, By Value (2014-2024)
Table 42: Global Metabolism & Inflammatory Market, By Value, 2014-2018 (USD Million)
Table 43: Global Metabolism & Inflammatory Market, By Value, Forecast, 2019-2024 (USD Million)
6.11 Global Immunology & Oncology Regenerative Medicine Market, By Value (2014-2024)
Table 44: Global Immunology & Oncology Market, By Value, 2014-2018 (USD Million)
Table 45: Global Immunology & Oncology Market, By Value, Forecast, 2019-2024 (USD Million)
6.12 Global Others Regenerative Medicine Market, By Value (2014-2024)
Table 46: Global Others Market, By Value, 2014-2018 (USD Million)
Table 47: Global Others Market, By Value, Forecast, 2019-2024 (USD Million)
6.13 Market attractiveness of Global Regenerative Medicine Market- By Application
Table 48: Market Opportunity Chart of global regenerative medicine Market - By Application, By Value (Year - 2024)
7.Global Regenerative Medicine Market: Regional Analysis
Table 49: Global Healthcare Landscape, By Select Region
7.1 Global Regenerative Medicine Market Size, By Region: Breakdown (%)
Table 50: Global Regenerative Medicine Market Size, By Region, 2018 (%)
Table 51: Global Regenerative Medicine Market Size, By Region, 2024 (%)
7.1.1 Global Regenerative Medicine Market Size, By Region, 2018 (%)
7.1.2 Global Regenerative Medicine Market Size, By Region, 2024 (%)
7.2 North America Regenerative Medicine Market: Growth and Forecast
7.2.1 By Value (2014-2018)
Table 52: North America Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
7.2.2 By Value (2019-2024)
Table 53: North America Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 53: North America Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 54: North America Diseases Outlook
Table 55: United States health care expenditure per capita, (In USD)
Table 56: Canada health care expenditure per capita (In USD)
Table 57: North America population aged 65 and above, 2013-2018 (% of total)
Table 58: Prevalence of musculoskeletal condition in North America, In million, 2013-2020E
Table 59: Prevalence of skin diseases in North America, In million. 2013-202E
Table 60: Prevalence of cardiovascular disease in North America, In million
Table 61: North America GDP, 2012-2017 (USD Trillion)
Table 62: North America GDP per capita, current prices, 2013-2023F (In USD)
7.2.3 North America Regenerative Medicine Market: Competitive Landscape
Table 63: North America Regenerative Medicine Market: Prominent Companies (2018)
7.2.4 By Type, By Value (2014-2018)
Table 64: North America Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.2.5 By Type, By Value (2019-2024)
Table 65: North America Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.2.6 By Application, By Value (2014-2018)
Table 66: North America Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.2.7 By Application, By Value (2019-2024)
Table 67: North America Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.3 North America Regenerative Medicine Market: Country Analysis (U.S and Canada)
Table 68: North America Regenerative Medicine Market Size, By Country, 2018 (%)
Table 69: North America Regenerative Medicine Market Size, By Country, 2024F (%)
7.4 Market Attractiveness of North America Regenerative Medicine Market- By Country
Table 70: Market Opportunity Chart of North America Regenerative Medicine Market - By Type, By Value (Year - 2024)
7.4.1 U.S Regenerative Medicine Market, By Value (2014-2024)
Table 71: USA Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 72: USA Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 71: USA Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 72: USA Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 73: Clinical trials supported by CIRM, By Disease, In 2018
Table 74: Percentage of adults aged 18-64 with insurance coverage in United States, By Poverty status, In 2018
Table 75: Percentage of individuals with insurance coverage in United States, By Age Group, In 2018
Table 76: Medical and Healthcare Research & Development Spending, 2014-2017 (In USD Million)
Table 77: Research and Development Expenditure of total U.S. Pharmaceutical Industry, 2013-2017, (USD Billion)
Table 78: NIH Funding For Stem Cell Research, 2015-2018 (In USD Million)
Table 79: NIH Funding For Regenerative Medicine Research, 2015-2018 (In USD Million)
Table 80: Prevalence of cardiovascular diseases in United States, In million
Table 81: Prevalence of Wounds in United States, By Type, (Percentage of Total)
Table 82: Percentage of people with chronic health conditions in United States
7.4.2 U.S Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 83: U.S. Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.4.3 U.S Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 84: U.S. Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.4.4 U.S Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 85: U.S. Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.4.5 U.S Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 86: U.S. Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.4.6 Canada Regenerative Medicine Market, By Value (2014-2024)
Table 87: Canada Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 88: Canada Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 89: Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
Table 90: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Table 91: Healthcare Expenditure in Canada, By Source Breakdown, In USD million
7.4.7 Canada Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 92: Canada Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.4.8 Canada Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 93: Canada Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.4.9 Canada Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 94: Canada Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.4.10 Canada Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 95: Canada Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.5 Europe Regenerative Medicine Market: Growth and Forecast
7.5.1 By Value (2014-2018)
Table 96: Europe Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
7.5.2 By Value (2019-2024)
Table 97: Europe Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 98: Regenerative Medicine in Clinical Trails, By Phase, 2018
Table 99: Europe Health Expenditure, By Select Country, 2017 & 2045 (% of GDP)
Table 100: Prevalence of Diabetes (Age 18+), 2017 & 2045E (In Million)
Table 101: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
Table 102: European Union, Population ages 65 and above, 2013-2018 (% of total)
Table 103: Per Capita Health Expenditure, By Select Country, 2018 (USD)
Table 104: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Table 105: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
7.5.3 Europe Regenerative Medicine Market: Competitive Landscape
Table 106: Europe Regenerative Medicine Market: Leading Companies (2018)
7.5.4 By Type, By Value (2014-2018)
Table 107: Europe Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.5.5 By Type, By Value (2019-2024)
Table 108: Europe Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.5.6 By Application, By Value (2014-2018)
Table 109: Europe Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.5.7 By Application, By Value (2019-2024)
Table 110: Europe Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.6 Europe Regenerative Medicine Market: Country Analysis (U.K ,Germany, France, Italy)
Table 111: Europe Regenerative Medicine Market Size, By Country, 2018 (%)
Table 112: Europe Regenerative Medicine Market Size, By Country, 2024F (%)
7.7 Market Attractiveness of Europe Regenerative Medicine Market- By Country
Table 113: Market Opportunity Chart of Europe Regenerative Medicine Market - By Type, By Value (Year - 2024)
7.7.1 U.K Regenerative Medicine Market, By Value (2014-2024)
Table 114: U.K. Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 115: U.K. Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 116: U.K, Total Number of Biotech Companies, By Sector, 2017
Table 117: U.K, Pharmaceutical R&D Spending, Euro Million, 2013-2016
Table 118: Proportional mortality in United Kingdom, In 2018
Table 119: Healthcare spending pattern in United Kingdom, In 2018
Table 120: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table 121: U.K, Population Ages 65 and Above (% of total), 2012-2018
7.7.2 U.K Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 122: U.K. Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.7.3 U.K Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 123: U.K. Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.7.4 U.K Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 124: U.K. Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.7.5 U.K Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 125: U.K. Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.5.6 Germany Regenerative Medicine Market, By Value (2014-2024)
Table 127: Germany Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 128: Germany Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 129: German Biotechnology companies expenditure on R&D, In Million Euros
Table 130: Prevalence of cardiovascular diseases in Germany, (In %)
Table 131: Proportional mortality in Germany, In 2018
Table 132: Healthcare spending pattern in Germany, In 2018, In USD
Table 133: Health insurance coverage in Germany, In 2018
Table 134: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table 135: Germany, Population ages 65 and above, 2012-2018 (% total)
7.5.7 Germany Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 136: Germany Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.5.8 Germany Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 137: Germany Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.5.9 Germany Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 138: Germany Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.5.14 Germany Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 139: Germany Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.5.10 France Regenerative Medicine Market, By Value (2014-2024)
Table 140: France Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 141: France Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 142: France, Number of Biotech Companies, By Type, 2017
Table 143: France, Prevalence of Cancer, 2018, (% of total)
Table 144: Prevalence of chronic diseases in France, In 2018
Table 145: Proportional mortality in France, In 2018
Table 146: Healthcare expenditure in France ( as a % of GDP)
Table 147: Healthcare spending pattern in France, In 2016 & 2050, In USD
7.5.11 France Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 148: France Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.5.12 France Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 149: France Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.5.13 France Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 150: France Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.5.14 France Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 151: France Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.5.15 Italy Regenerative Medicine Market, By Value (2014-2024)
Table 152: Italy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 153: Italy Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 154: Prevalence of chronic diseases in Italy, In 2018
Table 155: Prevalence of musculoskeletal condition in Italy, In million
Table 156: Prevalence of Chronic respiratory diseases in Italy, In Million
Table 157: Prevalence of cardiovascular diseases in Italy, In Thousands
Table 158: Italy, Health Expenditure, (% of GDP), 2013-2017 (USD)
Table 159: Italy, Population Ages 65 and Above (% of total), 2012-2018
Table 160: Prevalence of skin diseases in Italy, In million
Table 161: Italy, Spending on Healthcare, 2015 & 2040, (USD Per Person)
7.5.16 Italy Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 162: Italy Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.5.17 Italy Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 163: Italy Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.5.18 Italy Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 164: Italy Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.5.19 Italy Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 165: Italy Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.6 APAC Regenerative Medicine Market: Growth and Forecast
7.6.1 By Value (2014-2018)
7.6.2 By Value (2019-2024)
Table 166: APAC Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
Table 167: APAC Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 168: APAC, GDP, By Select Country, 2017 (In USD Trillion)
Table 169: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2018
Table 170: Obesity Rate, By Select Country, 2017 (In Percentage)
Table 171: Prevalence of musculoskeletal condition in Asia, 2013-2020F, In million
Table 172: Prevalence of chronic respiratory diseases in Asia, 2013-2020F, In million
Table 173: Population ages 65 and above, APAC Region, By Select Countries, 2018 (% of total)
Table 174: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
7.6.3 APAC Regenerative Medicine Market: Competitive Landscape
Table 175: APAC Regenerative Medicine Market: Leading Companies (2018)
7.6.4 By Type, By Value (2014-2018)
Table 176: APAC Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.6.5 By Type, By Value (2019-2024)
Table 177: APAC Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.6.6 By Application, By Value (2014-2018)
Table 178: APAC Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.6.7 By Application, By Value (2019-2024)
Table 178: APAC Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.7 APAC Regenerative Medicine Market: Country Analysis (Japan, India and China)
Table 180: APAC Regenerative Medicine Market Size, By Country, 2018 (%)
Table 181: APAC Regenerative Medicine Market Size, By Country, 2024F (%)
7.8 Market Attractiveness of APAC Regenerative Medicine Market- By Country
Table 182: Market Opportunity Chart of APAC Regenerative Medicine Market - By Type, By Value (Year - 2024)
7.8.1 India Regenerative Medicine Market, By Value (2014-2024)
Table 183: India Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 184: India Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 185: India, Population ages 65 and above, 2013-2018, In Million
Table 186: India, Share of Urban Population, 2012-2018 (In %)
Table 187: Prevalence of musculoskeletal condition in India, 2013-2020E, In Million
Table 188: Prevalence of chronic respiratory diseases in India, In Million
Table 189: Prevalence of skin diseases in India, In Million
Table 190: Prevalence of cardiovascular disease in India, In million
Table 191: Growth of biotechnology industry in India
Table 192: Healthcare expenditure pattern in India, 2016 & 2050, In USD $
Table 193: Prevalence of non- communicable diseases in India, In 2018
Table 194: India, GDP Growth Per Year, 2015-2019F (In %)
Table 195: India, Total Population, 2013-2023F (In Million)
7.8.2 India Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 196: India Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.8.3 India Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 197: India Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.8.4 India Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 198: India Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.8.5 India Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 199: India Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.8.6 Japan Regenerative Medicine Market, By Value (2014-2024)
Table 200: Japan Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 201: Japan Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 202: Japan Healthcare Expenditure Outlook (2017) (%)
Table 203: Prevalence of diabetes in Japan, In million
Table 204: Prevalence of cardiovascular disease in Japan, In million
Table 205: Japan, Cancer Prevalence, By Type, (2018)
Table 206: Proportional mortality in Japan, In 2018
Table 207: Japan, GDP Growth Per Year, 2015-2019F (In %)
Table 208: Japan, Population ages 65 and above, 2012-2018 (% of total)
7.8.7 Japan Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 209: Japan Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.8.8 Japan Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 210: Japan Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.8.9 Japan Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 211: Japan Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.8.10 Japan Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 212: Japan Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.8.11 China Regenerative Medicine Market, By Value (2014-2024)
Table 213: China Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 214: China Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 215: Prevalence of cardiovascular disease in China, In million
Table 216: Prevalence of diabetes in China, In million
Table 217: China, Population ages 65 and above, 2012-2018 (% of total)
Table 218: China Healthcare Expenditure Outlook (2018) (%)
Table 219: China, GDP Growth Per Year, 2015-2019 (In %)
Table 220: China, Share of Urban Population, 2012-2018 (In %)
Table 221: China, Total Population, 2013-2021F (In Million)
7.8.12 China Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 222: China Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.8.13 China Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 223: China Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.8.14 China Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 224: China Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.8.15 China Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 225: China Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.9 ROW Regenerative Medicine Market: Growth and Forecast
7.9.1 By Value (2014-2018)
7.9.2 By Value (2019-2024)
Table 226: ROW Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
Table 227: ROW Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
Table 228: Cancer Prevalence in MENA (% of total), 2018
Table 229: Cancer Prevalence in Latin America & Caribbean , (% of total), 2018
Table 230: Population ages 65 and above, By Select Country, 2017 (% of total)
Table 231: Population ages 60 or above, By Select Country, 2050 (% of total)
Table 232: Prevalence of musculoskeletal condition in Middle East and North Africa, In USD million
Table 233: Prevalence of chronic respiratory disease in Middle East and North Africa, In USD million
Table 234: Latin America and Caribbean, Population ages 65 and above 2012-2018 (% of total)
Table 235: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2018
Table 236: Middle East and North Africa, Population ages 65 and above (% of total)
Table 237: Middle East and North Africa, GDP, 2012-2018 (In USD Trillion)
Table 238: Prevalence of diabetes in Latin America ad Caribbean, In million
Table 239: Prevalence of diabetes in Middle East and North Africa, In million
7.9.4 By Type, By Value (2014-2018)
Table 240: ROW Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.9.5 By Type, By Value (2019-2024)
Table 241: ROW Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.9.6 By Application, By Value (2014-2018)
Table 242: ROW Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.9.7 By Application, By Value (2019-2024)
Table 243: ROW Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
7.9.8 ROW Regenerative Medicine Market: Country Analysis (Brazil)
Table 244: ROW Regenerative Medicine Market Size, By Country, 2018 (%)
Table 245: ROW Regenerative Medicine Market Size, By Country, 2024F (%)
7.9.9 Brazil Regenerative Medicine Market, By Value (2014-2024)
Table 246: Brazil Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
Table 247: Brazil Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
Table 248: Prevalence of diabetes in Brazil, In million
Table 249: Prevalence of chronic respiratory diseases in Brazil, In million
Table 250: Brazil, Population ages 65 and above, 2012-18 (% of total)
Table 251: Brazil, GDP, 2012-2018 (In USD Trillion)
Table 252: Prevalence of cardiovascular disease in Brazil, In Million
Table 253: Brazil health expenditure as a share of GDP, 2018
7.9.10 Brazil Regenerative Medicine Market, By Type, By Value (2014-2018)
Table 254: Brazil Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
7.9.11 Brazil Regenerative Medicine Market, By Type, By Value (2019-2024)
Table 255: Brazil Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
7.9.12 Brazil Regenerative Medicine Market, By Application, By Value (2014-2018)
Table 256: Brazil Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
7.9.13 Brazil Regenerative Medicine Market, By Application, By Value (2019-2024)
Table 257: Brazil Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
8.Global Regenerative Medicine Market: Competitive Landscape
Table 258: Global Regenerative Medicine Market Share, By Select Company, 2018 (In %)
8.1 Market share of Leading Global Companies
8.2 Global Regenerative Medicine Market : Collaborations, Partnerships and Alliances
8.3 Global Regenerative Medicine Market: Approved Products
8.4 Global Regenerative Medicine Market: Pipeline Products
Table 259: Global Regenerative Medicine Market – Pipeline Products, By Company
Table 260: Global Regenerative Medicine Market – Pipeline Products, By Therapeutic area
9.Global Regenerative Medicine Market Dynamics
9.1 Global Regenerative Medicine Market Drivers
9.1.1 Rapid Medical Research Infrastructure Development
9.1.2 Increase in prevalence of chronic and autoimmune diseases
9.1.3 Growing government expenditure in regenerative medicine research
9.2 Global Regenerative Medicine Market Restraints
9.2.1 High cost associated with regenerative medicines
9.3 Global Regenerative Medicine Market Trend
9.3.1 Emerging CAR-T cell therapy
9.3.2 3-D Bioprinting of tissues and organs
10.Porter Five Force Analysis
11.SWOT Analysis
12.Policy and Regulatory Landscape
13.Company Profiles
13.1 Vericel Corporation
Table 261: Vericel, Sales Revenue, 2014-2018 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook